Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2016 07:30 ET | Source: Chimerix, Inc.

Chimerix Announces Second Quarter 2016 Financial Results

- European Commission Granted Orphan Drug Designation for Brincidofovir for the Treatment of Adenovirus - - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., Aug. 08, 2016 (GLOBE NEWSWIRE)...
August 01, 2016 08:00 ET | Source: Chimerix, Inc.

Chimerix to Announce Second Quarter 2016 Financial Results on August 8, 2016

DURHAM, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals in areas of high unmet medical need, today announced that it...
June 07, 2016 08:00 ET | Source: Chimerix, Inc.

Chimerix to Participate in Panel on North Carolina’s Role in Biodefense Preparation at Medical, Biomedical and Biodefense Symposium

DURHAM, N.C., June 07, 2016 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals in areas of high unmet medical need, today announced that M....
May 09, 2016 07:30 ET | Source: Chimerix, Inc.

Chimerix Announces Top-Line Interim AdVise Data and First Quarter 2016 Financial Results

- Maintains strong financial position with $314.5 million in capital at quarter end - - Company to hold conference call at 8:30am ET today - DURHAM, N.C., May 09, 2016 (GLOBE NEWSWIRE) --...
May 03, 2016 18:00 ET | Source: Chimerix, Inc.

Chimerix to Announce First Quarter 2016 Financial Results on May 9, 2016

DURHAM, N.C., May 03, 2016 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that it will...
March 09, 2016 08:30 ET | Source: Chimerix, Inc.

Chimerix to Present at the Barclays Global Healthcare Conference

DURHAM, N.C., March 09, 2016 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel, oral antivirals to address unmet medical needs, today announced that Linda M....
March 01, 2016 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at Cowen and Company 36th Annual Health Care Conference

DURHAM, N.C., March 01, 2016 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel, oral antivirals to address unmet medical needs, today announced that M....
February 29, 2016 07:30 ET | Source: Chimerix, Inc.

Chimerix Announces Fourth Quarter and Full Year 2015 Financial Results

- Company to hold conference call at 8:30am ET today -- Survival and other key data from AdVise and matched controls to be reviewed with regulators in Summer 2016 - DURHAM, N.C., Feb. 29, 2016 ...
February 22, 2016 16:05 ET | Source: Chimerix, Inc.

Chimerix to Announce Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016

DURHAM, N.C., Feb. 22, 2016 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced...
February 20, 2016 21:15 ET | Source: Chimerix, Inc.

Chimerix Announces Presentation of Detailed Results From Phase 3 SUPPRESS Trial at BMT Tandem Meetings

Brincidofovir Shows On-Treatment Antiviral Effect in HCT Setting Despite Trial Not Meeting Primary Endpoint Company to Host Conference Call on February 22 at 8:00 a.m. EST to Provide...